Alpha Tau Medical (DRTSW) Free Cash Flow (2021 - 2022)

Alpha Tau Medical (DRTSW) posted Free Cash Flow of -$8.4 million for Q2 2022, down 33.07% sequentially from -$6.3 million in Q1 2022.

Alpha Tau Medical (DRTSW) Free Cash Flow (2021 - 2022) Analysis & Trends

Alpha Tau Medical has reported Free Cash Flow for 2 years, with the latest figure at -$8.4 million in Q2 2022.

Quarterly Free Cash Flow changed N/A year-over-year to -$8.4 million in Q2 2022, while the trailing twelve-month figure through Mar 2023 was -$8.4 million (down 33.07% YoY) and the FY2025 annual result came in at -$32.8 million, down 48.75% from the prior year.
Free Cash Flow declined to -$8.4 million in Q2 2022 per DRTSW's latest filing, from -$6.3 million in the prior quarter.
Over five years, Free Cash Flow peaked at -$2.5 million in Q1 2021 and troughed at -$8.4 million in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Free Cash Flow (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	1.01 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	572.80 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-563.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	437.80 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	292.04 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	433.84 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-95.09 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	477.44 Mn
10	Alpha Tau Medical	383.00 Mn	200.58 Mn	-	-

Download Data